Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 13, 2020Proceedings of the National Academy of SciencesOpen Access

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

View Full Paper
Ask AI
Bookmark
Share

Authors

EWEmmie de WitNational Institutes of HealthFFFriederike FeldmannNational Institutes of HealthJCJacqueline CroninNational Institutes of Health

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wit et al. (2020) studied this question.

synapsesocial.com/papers/6a2297500ae3bb3db2cd3b36https://doi.org/10.1073/pnas.1922083117
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea2015 · 209 citations
  2. 2Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge2019 · 284 citations
  3. 3Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV2020 · 1,817 citations
  4. 4Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses2017 · 1,641 citations
  5. 5Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques2018 · 51 citations